# ClinicalTrials.gov record NCT01078805

> PeptideScanner retained ClinicalTrials.gov record NCT01078805 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-26, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct01078805-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2012-06-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01078805-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01078805-teriparatide-v1.json
- Content SHA-256: `295184b315dd42f171c2a9c63eb0b0328ea47d453c44c829612c0c3b437459cc`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01078805 ([`ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c`](#source-ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01078805 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c`](#source-ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01078805 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c`](#source-ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c`](#source-ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c))

## Sources

<a id="source-ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c"></a>
- **ClinicalTrials.gov record NCT01078805 · retained source version 2012-06-26:f3b4eaea0a9c66df32e12aa5848ae64f431cb1e1cdf8269c72873e67bb57f7f0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01078805) (`ctg-observation-nct01078805-2012-06-26-f3b4eaea0a9c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01078805." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01078805-teriparatide-v1.json SHA-256: 295184b315dd42f171c2a9c63eb0b0328ea47d453c44c829612c0c3b437459cc.